Markets and Solutions
News and Data
Platforms and Tools
Practice Areas
Law Firm Solutions
Legal Education
Corporate and Government Solutions
Professional News Products
Professional News Solutions
Research and Development
Business Development
Compliance
Professional Services
Solutions
Organization Type
Home / Products & Services / Pharma & Life Sciences / Pharma Competitive Intelligence / Cortellis for Competitive Intelligence
Discover the undiscovered with Cortellis for Competitive Intelligence
Thomson Reuters Cortellis™ for Competitive Intelligence combines the same premier information used by the world's leading pharmaceutical companies from products such as Thomson Reuters Pharma™ and Thomson Reuters PartneringTM (formerly IDDB). Featuring daily updates and timely drug pipeline information expertly uncovered and integrated from a variety of sources and global meetings coverage, you'll always be on top of the latest developments. Whether you're putting together a pipeline analysis, or developing a comprehensive competitive intelligence study, Cortellis for Competitive Intelligence can get you to the critical information you need, faster.
Display Settings:
The application is best viewed at a monitor resolution of 1024 by 768 pixels or higher, and at 256 colors or more (High Color or True Color recommended).Browser Requirements:
Microsoft® Internet Explorer version 6.0 or higher, or alternatively Mozilla Firefox® 3.6 or higher, within a Windows XP operating environment. Internet Options: Exported results/reports are downloaded into a separate browser window. You must therefore ensure you temporarily disable/turn off any pop-up blockers on your computer, since the content will not export correctly when a pop-up blocker is active.Javascript:
The application uses JavaScript for defining menus and navigation, opening new windows and for the processing of requests. You must therefore enable the JavaScript option within your web browser to use the application successfully.Cookies:
In order to utilize all of the features available in the application, we recommend updating your Internet settings to enable or allow cookies for this website.Adobe Reader:
The application provides some exports in PDF format, to enable easy viewing and printing. You must therefore ensure that Adobe Reader is installed on your machine to export successfully. Adobe Reader is available for download free of charge, from the Adobe website.Case Study
Gaining a Full Picture of the Competitive Landscape for Evidence-based Decisions
Download our Case Study
* Approval Packages
* Disease Briefings
* US Trial Protocols
MT @Reuters_Health: Eli Lilly studying deaths of two patients on long-acting Zyprexa reut.rs/19fShl7 #FDA
Transition receives $7 million for returning type 2 diabetes drug TT-401 back to Eli Lilly in $262 million agreement
Mar from the Cortellis editorial team will be attending in Chicago the American Diabetes Association meeting later this week #2013ADA